I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
The use of targeted therapy against VEGF can not only inhibit tumor neovascularization, but also make the effectiveness of chemotherapeutic agents. VEGF and VEGFR are closely related to immune escape. Tumor growth requires new blood vessels to supply nutrients and oxygen, and VEGF can stimulate neovascularization.
targeted therapy
camrelizumab
squamous cell carcinoma of the head and neck
tumor growth
head and neck squamous cell carcinoma
- 0 views
- 19 Feb, 2024